RxAnte Receives $25M Growth Financing
- RxAnte, a Washington, D.C-based pharmacy care management business company, received $25M in Growth financing
- Trinity Capital Inc. (NASDAQ: TRIN, TRINL), provided the facility. $15M was drawn under the facility, and RxAnte has the option to draw an additional $10M, subject to the conditions under the agreement
- The company intends to use the funds to expand its business reach, continuing its work with health plans to bring down the $528 billion annual cost of under-use, over-use, and misuse of prescription drugs
- The company is a provider of predictive analytics and targeted clinical programs that improve medication prescribing and adherence
- A key component of its offering is its Mosaic Pharmacy Service, which provides value-based, in-home pharmacy services to medically complex and vulnerable seniors
- Mosaic directly improves prescribing, adherence, and drug therapy outcomes for patients under our care with the objective of improving quality and lowering total cost of care
